Trial Profile
A Randomised Controlled Trial Comparing Two Pertussis-containing Vaccines in Pregnancy and Vaccine Responses in UK Mothers and Their Infants
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Jan 2023
Price :
$35
*
At a glance
- Drugs DTaP poliovirus vaccine (Primary) ; Hib-DTaP-poliovirus vaccine; Hib-meningococcal vaccine group C conjugate; Meningococcal vaccine group C conjugate; Pneumococcal 13-valent CRM197 vaccine conjugate; RIX 4414
- Indications Pertussis
- Focus Pharmacodynamics
- Acronyms iMAP2
- 12 Jan 2023 Results assessing the impact of maternal DTaP/IPV immunisation on the infant immune response to IPV, published in the Vaccine
- 11 Jan 2018 Status changed from active, no longer recruiting to completed.
- 23 Aug 2017 Planned End Date changed from 1 Aug 2017 to 1 Dec 2017.